The ACME Laboratories Ltd. (DSE:ACMELAB)

The ACME Laboratories Balance Sheet

Financials in millions BDT. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	2,280	1,752	1,455	1,239	1,594	1,824
Short-Term Investments	1,139	56.32	50.45	48.14	180.12	278.07
Cash & Short-Term Investments	3,419	1,808	1,506	1,287	1,774	2,102
Cash Growth	50.00%	20.09%	17.00%	-27.45%	-15.60%	10.51%
Accounts Receivable	3,398	3,259	2,705	2,236	2,216	1,911
Other Receivables	33.12	20.13	19.89	19.81	19.93	19.73
Receivables	3,431	3,279	2,725	2,256	2,236	1,931
Inventory	12,498	11,871	10,234	7,879	5,124	5,231
Prepaid Expenses	0.51	17.36	15.61	14.01	13.09	12.06
Other Current Assets	6,282	6,886	6,655	5,907	6,193	5,430
Total Current Assets	25,630	23,863	21,136	17,343	15,341	14,706
Property, Plant & Equipment	32,433	31,729	29,243	25,599	25,100	24,689
Long-Term Investments	32.02	30.2	31.52	32.88	35.51	23.77
Other Intangible Assets	-	-	-	0	0.02	0.04
Total Assets	58,096	55,622	50,410	42,975	40,476	39,418
Accounts Payable	560.19	603.67	490.89	449	350.25	398.97
Accrued Expenses	604.21	600.01	553.26	574.63	508.59	419.86
Short-Term Debt	15,992	15,053	12,523	9,383	7,141	8,315
Current Portion of Long-Term Debt	2,175	2,115	2,054	2,328	2,601	2,459
Current Portion of Leases	20.23	21.49	21.86	22.33	14.27	11.64
Current Income Taxes Payable	3,515	3,022	3,255	2,661	2,856	2,367
Current Unearned Revenue	-	111.83	48.2	14.46	8.33	3.19
Other Current Liabilities	744.42	3.83	6.51	4.38	7.23	6.74
Total Current Liabilities	23,611	21,531	18,953	15,438	13,487	13,982
Long-Term Debt	6,657	6,753	6,168	4,175	5,442	5,107
Long-Term Leases	49.82	44.87	62.29	73.2	62.88	66.78
Long-Term Deferred Tax Liabilities	710.71	790.57	903.14	907.59	873.54	857.26
Total Liabilities	32,625	30,570	27,115	21,285	20,366	20,374
Common Stock	2,116	2,116	2,116	2,116	2,116	2,116
Additional Paid-In Capital	5,128	5,128	5,128	5,128	5,128	5,128
Retained Earnings	13,273	12,833	11,029	9,304	7,675	6,564
Comprehensive Income & Other	4,954	4,975	5,022	5,142	5,192	5,237
Shareholders' Equity	25,471	25,052	23,295	21,690	20,111	19,044
Total Liabilities & Equity	58,096	55,622	50,410	42,975	40,476	39,418
Total Debt	24,894	23,988	20,829	15,982	15,262	15,960
Net Cash (Debt)	-21,476	-22,179	-19,324	-14,694	-13,488	-13,858
Net Cash Per Share	-101.49	-104.82	-91.32	-69.44	-63.74	-65.49
Filing Date Shares Outstanding	211.6	211.6	211.6	211.6	211.6	211.6
Total Common Shares Outstanding	211.6	211.6	211.6	211.6	211.6	211.6
Working Capital	2,020	2,332	2,182	1,905	1,853	723.73
Book Value Per Share	120.37	118.39	110.09	102.50	95.04	90.00
Tangible Book Value	25,471	25,052	23,295	21,690	20,111	19,044
Tangible Book Value Per Share	120.37	118.39	110.09	102.50	95.04	90.00
Land	-	5,419	5,233	5,228	4,967	4,954
Buildings	-	12,236	9,649	8,112	6,770	6,618
Machinery	-	17,346	16,538	13,018	12,934	11,967
Construction In Progress	-	3,756	4,367	4,820	5,442	4,912

Updated Feb 2, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.